摘要: Combined-modality approaches for the treatment of non-small-cell lung cancer (NSCLC), head and neck cancer, esophageal offer survival benefits by improving locoregional control treating micrometastatic disease. The taxanes are active, tolerable drugs in these solid tumors have radiation-sensitizing activity.
cancernetwork.com参考文章(35)
C J Langer, Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer. Seminars in Radiation Oncology. ,vol. 9, pp. 108- 116 ,(1999)
D. D. Von Hoff, The taxoids: same roots, different drugs. Seminars in Oncology. ,vol. 24, ,(1997)
John T. Chaffey, Samuel Hellman, Differing Responses to Radiation of Murine Bone Marrow Stem Cells in Relation to the Cell Cycle Cancer Research. ,vol. 31, pp. 1613- 1615 ,(1971)
Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb, , Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Journal of Clinical Oncology. ,vol. 18, pp. 2354- 2362 ,(2000) , 10.1200/JCO.2000.18.12.2354
Vincent Favaudon, Christophe Hennequin, Nicole Giocanti, Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Research. ,vol. 56, pp. 1842- 1850 ,(1996)
J Zalcberg, M Millward, J Bishop, M McKeage, A Zimet, G Toner, M Friedlander, C Barter, D Rischin, C Loret, R James, N Bougan, J Berille, Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 16, pp. 1948- 1953 ,(1998) , 10.1200/JCO.1998.16.5.1948
A M Mauer, G A Masters, D J Haraf, P C Hoffman, S M Watson, H M Golomb, E E Vokes, Phase I study of docetaxel with concomitant thoracic radiation therapy. Journal of Clinical Oncology. ,vol. 16, pp. 159- 164 ,(1998) , 10.1200/JCO.1998.16.1.159
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara, Hideki Nishikawa, Yoshiki Takada, Shinzoh Kudoh, Nobuyuki Katagami, Yutaka Ariyoshi, Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2692- 2692 ,(1999) , 10.1200/JCO.1999.17.9.2692
W Curran, C Scott, C Langer, R Komaki, J Lee, S Hauser, B Movsas, T Wasserman, A Russell, R Byhardt, W Sause, J Cox, Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 Lung Cancer. ,vol. 29, pp. 93- ,(2000) , 10.1016/S0169-5002(00)80304-9
Toyozo Terasima, L.J. Tolmach, Variations in Several Responses of HeLa Cells to X-Irradiation during the Division Cycle Biophysical Journal. ,vol. 3, pp. 11- 33 ,(1963) , 10.1016/S0006-3495(63)86801-0